SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Amrutanjan Healthcar - Quaterly Results

10 Nov 2023 Evaluate
The sales is pegged at Rs. 993.12 millions for the September 2023 quarter. The mentioned figure indicates decline with the sales recorded at Rs. 1107.19 millions during the year-ago period.The Company to register a -46.33%  fall in the net profit for the quarter ended September 2023.Operating profit for the quarter ended September 2023 decreased to 107.90 millions as compared to 189.61 millions of corresponding quarter ended September 2022.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202309 202209 % Var 202309 202209 % Var 202303 202203 % Var
Sales 993.12 1107.19 -10.30 1771.75 1816.73 -2.48 3796.36 4058.42 -6.46
Other Income 39.48 30.32 30.21 76.34 60.44 26.31 145.42 153.83 -5.47
PBIDT 107.90 189.61 -43.09 216.34 253.03 -14.50 589.34 948.56 -37.87
Interest 0.30 0.20 50.00 0.54 0.44 22.73 0.77 4.85 -84.12
PBDT 107.60 189.41 -43.19 215.80 252.59 -14.57 588.57 943.71 -37.63
Depreciation 15.54 15.21 2.17 29.46 25.88 13.83 52.12 37.95 37.34
PBT 92.06 174.20 -47.15 186.34 226.71 -17.81 536.45 905.76 -40.77
TAX 23.56 46.56 -49.40 47.71 62.43 -23.58 138.11 233.88 -40.95
Deferred Tax 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
PAT 68.50 127.64 -46.33 138.63 164.28 -15.61 398.34 671.88 -40.71
Equity 28.91 29.23 -1.09 29.23 29.23 0.00 29.23 29.23 0.00
PBIDTM(%) 10.86 17.13 -36.56 12.21 13.93 -12.33 15.52 23.37 -33.58

Amrutanjan Healthcar Share Price

546.50 7.85 (1.46%)
17-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1675.20
Dr. Reddys Lab 1235.40
Cipla 1238.30
Zydus Lifesciences 942.55
Lupin 2324.25
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×